Advanced search

Filters

Capitalization

Sector

Select all

Add a keyword

Announcement Date

Since

Until

839 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Astrazeneca looks to double revenue in 'new era of growth'	05-22	AQ
AstraZeneca says building China supply chain amid US-China tensions	05-21	RE
AstraZeneca aims for $80 bln in total revenue by 2030	05-21	RE
Stocks fall but pound up as IMF ups UK forecast	05-21	AN
Stocks fall but pound up as IMF ups UK forecast	05-21	AN
Transcript : AstraZeneca PLC - Analyst/Investor Day	05-21
FTSE 100 declines after Asian stocks fall	05-21	AN
AstraZeneca aims to almost double sales by 2030	05-21	CF
AstraZeneca eyes new era of growth with bold new revenue aim	05-21	AN
AstraZeneca plots "new era of growth"; SSP confident	05-21	AN
AstraZeneca aims for $80 bln in total revenue by 2030	05-21	RE
AstraZeneca : Investor Day Biographies	05-21	PU
AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post 2030	05-21	BU
Astrazeneca set to build cancer drug plant in Singapore	05-21	AQ
AstraZeneca announces $1.5b ADC manufacturing facility	05-20	AQ
AstraZeneca : plans $1.5 billion manufacturing facility for antibody drug conjugates (ADCs) in Singapore - Form 6-K	05-20	PU
AstraZeneca plans to build manufacturing plant in Singapore	05-20	AN
AstraZeneca Plans $1.5 Billion Manufacturing Facility in Singapore	05-20	DJ
AstraZeneca to build $1.5-bln cancer drug plant in Singapore	05-20	RE
AstraZeneca : Transaction by Person Discharging Managerial Responsibilities - Form 6-K	05-15	PU
Astrazeneca - Q1 2024 results	04-26	AQ
Transcript : AstraZeneca PLC, Q1 2024 Earnings Call, Apr 25, 2024	04-25
AstraZeneca: strong sales growth in Q1	04-25	CF
AstraZeneca upbeat as cancer drugs underpin sales growth	04-25	AN
Miner Anglo American reviews takeover bid from rival BHP	04-25	AN
Miner Anglo American eyes rival BHP takeover	04-25	AN
Q1 2024 results	04-25	BU
BRITAIN'S PROXY BATTLE REQUIRES A UNITED FRONT	04-18	AQ
Global markets live: BP, Apple, Vodafone, Ford, Lockheed Martin...	04-12
AstraZeneca Executives' Compensation Policy Passes With Low Shareholder Approval	04-11	DJ
AstraZeneca shareholders approve 2024 pay policy in boost to CEO Soriot	04-11	RE
AstraZeneca : Results of Annual General Meeting held on 11 April 2024	04-11	PU
AstraZeneca shareholders approve 2024 pay policy at AGM	04-11	RE
Europe takes hit on nerves ahead of ECB decision	04-11	AN
AstraZeneca announces dividend hike ahead of CEO pay vote	04-11	RE
PASCAL'S PROXY PAY PALAVER	04-10	AQ
ASTRAZENECA : AstraZeneca should not be overlooked for long	04-03
Global markets live: UBS, AT&T, Tesla, United Airlines, Humana, Wanda...	04-02
AstraZeneca CEO Soriot on Pharmaceuticals in China	03-27	MT
China to speed up 'new productive forces', vice president says	03-26	RE
German industry sceptical of China's vow to treat foreign firms equally	03-25	RE
AstraZeneca : 2023 Sustainability Highlights presentation	03-22	PU
AstraZeneca follows rival Boehringer in capping out-of-pocket costs for inhalers	03-18	RE
AstraZeneca caps patient out-of-pocket costs at $35 per month for its US inhaled respiratory portfolio	03-18	BU
AstraZeneca : Transaction by Person Discharging Managerial Responsibilities - Form 6-K	03-12	PU
AstraZeneca : Proxy Form for 2024 AGM	03-07	PU
AstraZeneca Planning GBP650 Million Investment for U.K. Programs	03-06	DJ
AstraZeneca : Transaction by Person Discharging Managerial Responsibilities - Form 6-K	03-06	PU
AstraZeneca to invest 650 million pounds in UK to boost 'pandemic preparedness'	03-06	RE
GSK CEO Emma Walmsley's total pay rises 51% to nearly 13 million pounds in 2023	03-01	RE

No results for this search